Multiple Sclerosis-Simvastatin Trial 2

Condition:   Secondary Progressive Multiple Sclerosis (SPMS)
Interventions:   Drug: Simvastatin;   Drug: Placebo
Sponsors:   University College, London;   University of Edinburgh;   Queen Mary University of London;   London School of Hygiene and Tropical Medicine;   University of Leeds;   The Leeds Teaching Hospitals NHS Trust;   Imperial College Healthcare NHS Trust
Active, not recruiting


Author: